Australia increases product registration fee under new IVD framework - update
This article was originally published in RAJ Devices
Australian in vitro diagnostic companies wanting to market their products under the newly enacted IVD legislative framework will have to pay an initial fee of Aus$790 (US $720) to register their products with the Therapeutic Goods Administration1,2.
You may also be interested in...
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.
An ambitious action plan drawn by an EU task force, if implemented on a priority basis by the European Commission, could increase the EU’s capacity to advise on, assess and analyze big data.
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.